TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/31/2024
Back to search
Official data from USPTO
CELLFE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CELLFE
ST13
US500000088844359Class
5, 9, 10
Filing
88844359
Registration
6591175
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
12/31/2024
Trademark type
Word
Nice classes
5, 9, 10
Filing date
03/23/2020
Registration date
12/14/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/14/2021
Last transaction
12/31/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/09/2021
First use in commerce
08/09/2021
Drawing code
4
Owner type
03
Owner location
Alameda, CA
Examiner
KEAN, AMY C
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CELLFE, INC.
Representatives
Vladimir Y. Gusev Polygon IP, LLP
Technical classification
Nice Classes
Class 5Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Therapeutic pharmaceuticals for changing immune response and improving regenerative capacities for use in the treatment of medical conditions and diseasescancerblood diseasesinfectious diseasesautoimmune diseases; Therapeutic pharmaceuticals for changing immune response and improving regenerative capacities for the prevention of medical conditions and diseasescancerblood diseasesinfectious diseasesautoimmune diseases; Living cells for treating medical conditions and diseasescancerblood diseasesinfectious diseasesautoimmune diseases; Living cells for medical purposesfor creating cell therapies
Class 9
Laboratory apparatus in the nature of microfluidic chips for scientific research for use in the delivery of macromoleculesnanoparticlespolymers to cells; Laboratory apparatus kits comprising microfluidic chips and a pressurized gas system comprised of flow control instrumentsgas supplyflow channelscontainersvessels for scientific research; Laboratory apparatus kits comprising microfluidic chips and pumping systems comprised of flow control instrumentsflow pumpsflow channelscontainersvessels for scientific research
Class 10
Medical apparatus in the nature of microfluidic chips for use in cell therapy and immunotherapy for use in the delivery of macromoleculesnanoparticles and polymers to cells; Medical apparatus in the nature of a kit comprising microfluidic chipsa control apparatusa pressurized gas system comprised of flow control instrumentsgas supplyflow channelscontainersvessels for delivery of cell therapyimmunotherapymedical treatmentsdiagnostics; Medical equipment in the nature of a kit comprising microfluidic chipsa control apparatusa pumping system comprised of flow control instrumentsflow pumpsflow channelscontainersvessels for delivery of cell therapyimmunotherapymedical treatmentsdiagnostics; Medical instruments in the nature of a medical kit comprising disposable microfluidic chipsdisposable tubing and disposable containers for medical purposesgenerating cells to treat cancerblood diseasesinfectious diseasesautoimmune diseases all for use in cell therapy and immunotherapy medical treatments
Publications
History of USPTO decisions and trademark events.
34 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/31/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/31/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/14/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/10/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/09/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/22/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/21/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/21/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/16/2021
GNRT
NON-FINAL ACTION E-MAILED
10/16/2021
CNRT
SU - NON-FINAL ACTION - WRITTEN
10/16/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/27/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/27/2021
IUAF
USE AMENDMENT FILED
09/15/2021
EISU
TEAS STATEMENT OF USE RECEIVED
09/15/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/16/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/19/2021
PUBO
PUBLISHED FOR OPPOSITION
01/19/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/30/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/16/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
12/16/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/16/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
12/16/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/16/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/05/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/04/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/04/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/15/2020
GNRT
NON-FINAL ACTION E-MAILED
06/15/2020
CNRT
NON-FINAL ACTION WRITTEN
06/15/2020
DOCK
ASSIGNED TO EXAMINER
06/14/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/26/2020
NWAP
NEW APPLICATION ENTERED
03/26/2020
Continuous trademark protection
Get notified about every new filing that threatens CELLFE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.